Garland Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.72M Sell
9,283
-23,455
-72% -$4.35M 5.47% 3
2025
Q1
$6.86M Sell
32,738
-4,635
-12% -$971K 6.42% 1
2024
Q4
$6.64M Sell
37,373
-810
-2% -$144K 5.44% 2
2024
Q3
$7.54M Sell
38,183
-6,375
-14% -$1.26M 5.8% 2
2024
Q2
$7.64M Sell
44,558
-100
-0.2% -$17.2K 5.4% 2
2024
Q1
$8.13M Sell
44,658
-470
-1% -$85.6K 5.39% 3
2023
Q4
$6.99M Sell
45,128
-1,960
-4% -$304K 4.91% 2
2023
Q3
$7.02M Sell
47,088
-75
-0.2% -$11.2K 4.95% 2
2023
Q2
$6.35M Buy
47,163
+175
+0.4% +$23.6K 4.27% 5
2023
Q1
$7.49M Sell
46,988
-2,770
-6% -$441K 5.09% 2
2022
Q4
$8.04M Sell
49,758
-5
-0% -$808 5.24% 1
2022
Q3
$6.68M Buy
49,763
+25
+0.1% +$3.36K 5.81% 1
2022
Q2
$7.62M Sell
49,738
-1,307
-3% -$200K 5.69% 1
2022
Q1
$8.28M Sell
51,045
-750
-1% -$122K 5.48% 2
2021
Q4
$7.01M Sell
51,795
-3,450
-6% -$467K 4.84% 7
2021
Q3
$5.96M Sell
55,245
-300
-0.5% -$32.4K 4.26% 8
2021
Q2
$6.26M Sell
55,545
-100
-0.2% -$11.3K 4.4% 7
2021
Q1
$6.02M Sell
55,645
-200
-0.4% -$21.6K 4.55% 7
2020
Q4
$5.98M Buy
55,845
+175
+0.3% +$18.8K 5.07% 6
2020
Q3
$4.88M Sell
55,670
-200
-0.4% -$17.5K 4.35% 9
2020
Q2
$5.49M Sell
55,870
-1,075
-2% -$106K 4.97% 4
2020
Q1
$4.34M Sell
56,945
-1,175
-2% -$89.5K 3.95% 11
2019
Q4
$5.15M Hold
58,120
3.73% 11
2019
Q3
$4.4M Sell
58,120
-300
-0.5% -$22.7K 3.15% 19
2019
Q2
$4.25M Sell
58,420
-755
-1% -$54.9K 3.02% 20
2019
Q1
$4.77M Buy
59,175
+1,050
+2% +$84.6K 3.31% 15
2018
Q4
$5.36M Buy
58,125
+387
+0.7% +$35.7K 3.87% 6
2018
Q3
$5.46M Sell
57,738
-882
-2% -$83.4K 3.7% 8
2018
Q2
$5.43M Sell
58,620
-1,006
-2% -$93.2K 3.78% 6
2018
Q1
$5.64M Buy
59,626
+425
+0.7% +$40.2K 3.93% 5
2017
Q4
$5.73M Sell
59,201
-8,055
-12% -$779K 3.76% 5
2017
Q3
$5.98M Buy
67,256
+671
+1% +$59.6K 3.82% 3
2017
Q2
$4.83M Buy
66,585
+2,350
+4% +$170K 2.96% 12
2017
Q1
$4.19M Sell
64,235
-1,500
-2% -$97.7K 3.27% 18
2016
Q4
$4.12M Buy
65,735
+2,500
+4% +$157K 2.95% 19
2016
Q3
$3.99M Buy
63,235
+100
+0.2% +$6.31K 3.23% 21
2016
Q2
$3.91M Buy
63,135
+800
+1% +$49.5K 3.12% 20
2016
Q1
$3.77M Buy
+62,335
New +$3.77M 2.89% 22